Insider Buying: OneMedNet (NASDAQ:ONMD) Insider Buys $14,748.06 in Stock

OneMedNet Corporation (NASDAQ:ONMD) insider Jeffrey Yu purchased 21,374 shares of the business’s stock in a transaction dated Wednesday, August 27th. The shares were purchased at an average cost of $0.69 per share, for a total transaction of $14,748.06. Following the purchase, the insider directly owned 6,976,934 shares of the company’s stock, valued at $4,814,084.46. This trade represents a 0.31% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Jeffrey Yu also recently made the following trade(s):

• On Thursday, September 25th, Jeffrey Yu acquired 1,250 shares of OneMedNet stock. The shares were purchased at an average cost of $1.03 per share, with a total value of $1,287.50.
• On Wednesday, September 24th, Jeffrey Yu bought 17,200 shares of OneMedNet stock. The stock was acquired at an average cost of $1.02 per share, for a total transaction of $17,544.00.
• On Tuesday, September 23rd, Jeffrey Yu purchased 5,700 shares of OneMedNet stock. The shares were acquired at an average cost of $0.93 per share, with a total value of $5,301.00.
• On Monday, September 22nd, Jeffrey Yu acquired 400 shares of OneMedNet stock. The stock was acquired at an average price of $0.95 per share, for a total transaction of $380.00.
• On Friday, September 19th, Jeffrey Yu bought 1,250 shares of OneMedNet stock. The shares were acquired at an average cost of $0.89 per share, with a total value of $1,112.50.
• On Thursday, September 18th, Jeffrey Yu purchased 700 shares of OneMedNet stock. The stock was bought at an average cost of $0.91 per share, for a total transaction of $637.00.
• On Friday, September 5th, Jeffrey Yu acquired 2,100 shares of OneMedNet stock. The shares were bought at an average cost of $0.86 per share, with a total value of $1,806.00.
• On Thursday, September 4th, Jeffrey Yu acquired 11,810 shares of OneMedNet stock. The stock was bought at an average price of $0.87 per share, with a total value of $10,274.70.
• On Wednesday, September 3rd, Jeffrey Yu bought 11,670 shares of OneMedNet stock. The shares were bought at an average price of $0.81 per share, for a total transaction of $9,452.70.
• On Tuesday, September 2nd, Jeffrey Yu bought 24,319 shares of OneMedNet stock. The shares were bought at an average price of $0.85 per share, with a total value of $20,671.15.

OneMedNet Trading Down 2.7%

Shares of ONMD stock traded down $0.04 on Wednesday, reaching $1.42. The company had a trading volume of 298,140 shares, compared to its average volume of 762,577. The stock has a market cap of $72.43 million, a PE ratio of -28.40 and a beta of 1.09. The company has a 50-day moving average of $1.77 and a 200-day moving average of $0.99. OneMedNet Corporation has a 12 month low of $0.30 and a 12 month high of $4.22.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.18 million for the quarter.

Institutional Trading of OneMedNet

Several hedge funds have recently added to or reduced their stakes in the stock. Correct Capital Wealth Management bought a new position in shares of OneMedNet during the 3rd quarter valued at approximately $4,910,000. Ashton Thomas Private Wealth LLC bought a new stake in shares of OneMedNet in the 3rd quarter worth approximately $25,000. Finally, Exencial Wealth Advisors LLC lifted its stake in OneMedNet by 141.3% in the third quarter. Exencial Wealth Advisors LLC now owns 3,599,460 shares of the company’s stock valued at $3,923,000 after purchasing an additional 2,107,598 shares during the last quarter. Institutional investors own 0.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ONMD. Wall Street Zen upgraded OneMedNet to a “hold” rating in a report on Friday, September 26th. Weiss Ratings restated a “sell (d-)” rating on shares of OneMedNet in a report on Tuesday, October 14th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.